This HIF-1α stabilization, in turn, promotes usage of the glycolytic pathway and promotes liver fibrosis in murine models of NAFLD [160], potentially signaling a key step in the transition from NASH to cirrhosis. The gene discussed is HIF1A; the disease is metabolic dysfunction-associated steatotic liver disease.